Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug
Crossref DOI link: https://doi.org/10.1186/s43094-021-00323-2
Published Online: 2021-09-08
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Younus, Saleena http://orcid.org/0000-0002-7174-5179
Vinod Chandra, S. S.
Nair, Achuth Sankar S.
Text and Data Mining valid from 2021-09-08
Version of Record valid from 2021-09-08
Article History
Received: 17 March 2021
Accepted: 22 August 2021
First Online: 8 September 2021
Declarations
:
: Not applicable.
: The authors declare that they have no competing interests.